Concepedia

Haiying Xu

HX

10

Publications

466

Citations

10

H-Index

2008

Active since

Affiliations

Hubei University of Chinese Medicine(Current)

Chongqing University

Union Hospital

Huazhong University of Science and Technology

Haiying Xu is an author at Hubei University of Chinese Medicine specializing in pharmacology, engineering, and medicine.

ORCID

Top concepts

Publications per year

2008–2024

10

Publications

10

Royal jelly acid suppresses hepatocellular carcinoma tumorigenicity by inhibiting H3 histone lactylation at H3K9la and H3K14la sites

Haiying Xu, Lanqing Li, Shunshun Wang et al. · Phytomedicine · 2023 · 147 citations · Full text

Lumican promotes calcific aortic valve disease through H3 histone lactylation

Yuming Huang, Chunli Wang, Tingwen Zhou et al. · European Heart Journal · 2024 · 93 citations

Cepharanthine inhibits hepatocellular carcinoma cell growth and proliferation by regulating amino acid metabolism and suppresses tumorigenesis <i>in vivo</i>

Fan Feng, Lianhong Pan, Jiaqin Wu et al. · International Journal of Biological Sciences · 2021 · 55 citations · Full text

Andrographolide ameliorates aortic valve calcification by regulation of lipid biosynthesis and glycerolipid metabolism targeting MGLL expression in vitro and in vivo

Chunli Wang, Yuming Huang, Xianqiong Liu et al. · Cell Calcium · 2021 · 34 citations

, , +11

Daidzin inhibits hepatocellular carcinoma survival by interfering with the glycolytic/gluconeogenic pathway through downregulation of <scp>TPI1</scp>

Lanqing Li, Haiying Xu, Linghang Qu et al. · BioFactors · 2022 · 33 citations

Rows per page

1–5 of 10